TMEM119 and the RFP tracer overlapped very reliably in experimental tumors (Figure S3B) and these TMEM119+RFP+ microglial cells accounted for approximately 25% of all Iba1-positive cells of the tumor parenchyma (Figure S3C). Here, TMEM119 is linked to neoplasm.